Your browser doesn't support javascript.
loading
Immune activation and evolution through chemotherapy plus checkpoint blockade in triple-negative breast cancer.
Koh, Siang-Boon; Ellisen, Leif W.
Affiliation
  • Koh SB; Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA; Harvard Medical School, Boston, MA 02115, USA.
  • Ellisen LW; Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA; Harvard Medical School, Boston, MA 02115, USA; Ludwig Center at Harvard, Boston, MA 02115, USA. Electronic address: lellisen@mgh.harvard.edu.
Cancer Cell ; 39(12): 1562-1564, 2021 12 13.
Article in En | MEDLINE | ID: mdl-34767761
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triple Negative Breast Neoplasms Limits: Humans Language: En Journal: Cancer Cell Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triple Negative Breast Neoplasms Limits: Humans Language: En Journal: Cancer Cell Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Country of publication: